Couban, S., Savoie, L., Abou Mourad, Y. A., Leber, B., Minden, M., Turner, R., Palada, V., Shehata, N., Christofides, A., & Lachance, S. (2014). Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus. Current Oncology, 21(2), e265-e309. https://doi.org/10.3747/co.21.1834
Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus. /
Couban, Stephen; Savoie, L.; Abou Mourad, Y. A. 等.
在:
Current Oncology, 卷 21, 号码 2, 2014, 页码 e265-e309.
科研成果: 期刊稿件 › 文章 › 同行评审
Couban, S, Savoie, L, Abou Mourad, YA, Leber, B, Minden, M, Turner, R, Palada, V, Shehata, N, Christofides, A & Lachance, S 2014, 'Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus', Current Oncology, 卷 21, 号码 2, 页码 e265-e309. https://doi.org/10.3747/co.21.1834
Couban S, Savoie L, Abou Mourad YA, Leber B, Minden M, Turner R 等. Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus. Current Oncology. 2014;21(2):e265-e309. doi: 10.3747/co.21.1834
Couban, Stephen ; Savoie, L. ; Abou Mourad, Y. A. 等. / Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia : A Canadian consensus. 在: Current Oncology. 2014 ; 卷 21, 号码 2. 页码 e265-e309.
@article{ba95eb39cb6e44089f3682ea8b40a892,
title = "Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: A Canadian consensus",
keywords = "ALL, Acute lymphoblastic leukemia, Hematology, Philadelphia chromosome-positive, Tyrosine kinase inhibitors",
author = "Stephen Couban and L. Savoie and {Abou Mourad}, {Y. A.} and B. Leber and M. Minden and R. Turner and V. Palada and N. Shehata and A. Christofides and S. Lachance",
year = "2014",
doi = "10.3747/co.21.1834",
language = "English",
volume = "21",
pages = "e265--e309",
journal = "Current Oncology",
issn = "1198-0052",
publisher = "Multimed Inc.",
number = "2",
}
TY - JOUR
T1 - Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia
T2 - A Canadian consensus
AU - Couban, Stephen
AU - Savoie, L.
AU - Abou Mourad, Y. A.
AU - Leber, B.
AU - Minden, M.
AU - Turner, R.
AU - Palada, V.
AU - Shehata, N.
AU - Christofides, A.
AU - Lachance, S.
PY - 2014
Y1 - 2014
KW - ALL
KW - Acute lymphoblastic leukemia
KW - Hematology
KW - Philadelphia chromosome-positive
KW - Tyrosine kinase inhibitors
UR - http://www.scopus.com/inward/record.url?scp=84898787747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898787747&partnerID=8YFLogxK
U2 - 10.3747/co.21.1834
DO - 10.3747/co.21.1834
M3 - Article
AN - SCOPUS:84898787747
SN - 1198-0052
VL - 21
SP - e265-e309
JO - Current Oncology
JF - Current Oncology
IS - 2
ER -